Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPOÂ® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients